Applications of FTIR in Polymer Process Development

This on-demand webinar will cover: General introduction on new K-REACH Notifications/registration requirement and exemptions on chemical substance Time line for registration Polymer of low concern and its exemption Registration requirements and data reduction for intermediates Data requirements on registrations and notifications Cost of registration Information communication through supply chain Penalties

The management of hazardous waste in China is becoming a more and more important topic as the central government has been putting a lot of effort in the regulation on the hazardous chemicals and the improvement of the environmental quality. The latest version of the Inventory of Hazardous Wastes was published in March 2016. The new version became effective on Aug 1st 2016 and included significant changes compared to its predecessor, the 2008 version. However, industry has encountered some problems relating to the implementation of the Inventory. So ChemLinked invited Ms. Amy Tu to give our readers a comprehensive introduction to the management of hazardous waste in China.

Leachable compounds are currently only evaluated on the toxicological risk they pose to the patient. The effects that leachable compounds have on the quality and safety of pharmaceutical drug products, especially protein drug products, is often overlooked. Interactions of reactive leachable compounds with protein drug products can lead to a loss of efficiency, decrease of stability and increased immunogenicity in the patient population at risk. This webinar describes reactive leachable compounds, the scientific basis to predict leachable-protein interactions and a proof of concept.

Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.